Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults.

Tino F SchwarzStephanie VolpeGregory CatteauRoman ChlibekMarie Pierre DavidJan Hendrik RichardusHimal LalLidia OostvogelsKarlis PauksensStephanie RavaultLars RomboGerard SonderJan SmetanaThomas HeinemanAdriana Bastidas

Published in: Human vaccines & immunotherapeutics (2018)

After vaccination with HZ/su, both cell mediated and humoral immunity remained above pre-vaccination levels up to year 9 regardless of age group. Immune responses are predicted to remain above baseline up to 15 years post initial vaccination.

Keyphrases

immune response
dendritic cells
toll like receptor
single cell
physical activity
cell therapy
inflammatory response
mesenchymal stem cells
protein kinase